trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['award', 't-dxd', 'tnbc']
 merit award winner presents repeat biopsies identify more candidates for t-dxd among pts with metastatic tnbc. biopsy again if safe and feasible if prior biopsies were her2 ihc 0. #asco23 
Medical Oncologist, Director of Cancer Equity & Clinical Director of Breast Oncology at Mass General Hospital; Professor, Harvard Medical School. Views my own.